agilon health, inc. (NYSE:AGL) is one of the penny stocks with potential to rise 1000 percent. agilon health said on March 18, 2026, that it would implement a 1-for-25 reverse stock split of its ...
Netflix's 10-for-1 stock split in November was among the more notable stock splits of recent years. Booking Holdings' recently announced split plans may have surprised investors, despite its high ...
The company’s new C.E.O. said he saw opportunities to fix and grow the food giant — and cut prices for consumers. By Julie Creswell Just a few months ago, the food giant Kraft Heinz had a plan to ...
WASHINGTON — Array Labs, a Silicon Valley startup developing radar-based Earth observation satellites, announced Jan. 5 it raised $20 million in a Series A round as it pushes to bring lower-cost ...
iPad users once again gain access to classic Split View multitasking in iPadOS 26.2. It’s back to being the best way to use two applications side-by-side on your iPad. Apple nerfed Split View in ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 7 minutes ...
ServiceNow Inc. plans a 5-for-1 stock split, which its CEO said is aimed at making the share price more accessible for employees and investors. The stock closed Wednesday at $912, which was the ...
Q. I have used the Excel functions LEFT, MID, and RIGHT to dissect cells. However, I have some spreadsheets where each piece of information is a different length and uses different delimiters. Is ...
Netflix‘s shares are about to become more affordable. The streaming giant announced Thursday that its board approved a 10-for-1 forward stock split of Netflix common stock. “The purpose of the stock ...
Netflix Inc. approved a 10-for-1 stock split to make its share price more accessible for employees who participate in the company’s stock option program. It’s the second split in the last 10 years for ...
Johnson & Johnson said Tuesday it plans to separate its artificial hip and knee business into a stand-alone company to be called DePuy Synthes—the latest attempt to slim down by the healthcare giant.